NCT02988869View on ClinicalTrials.gov

Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination Treatment

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions

COPD

Interventions

DRUG

Tiotropium/Formoterol

Tiotropium/Formoterol 18/12 mcg Inhalation Powder (1 puff) once daily via Discair®

DRUG

Tiotropium

Tiotropium 18 mcg Inhalation Powder (1 puff) once daily via Handihaler

DRUG

Formoterol

Formoterol 12 mcg Inhalation Powder (1 puff) twice daily via Aerolizer

DRUG

Tiotropium

Tiotropium 18 mcg Inhalation Powder (1 puff) once daily via Handihaler

Trial Locations (1)

34020

Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul

All Listed Sponsors

lead

Neutec Ar-Ge San ve Tic A.Ş

INDUSTRY

NCT02988869 - Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination Treatment | Biotech Hunter | Biotech Hunter